SEC Form 4 · accession 0001225208-15-003218
CLOROX CO /DE/ · CLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacqueline P Kane
Officer — SVP- HR & Corporate Affairs
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000021076
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2015 | M | 18,824 | $63.95 | A | 45,993 | D | |
| Common Stock | Feb 5, 2015 | M | 6,686 | $61.16 | A | 52,679 | D | |
| Common StockF2 | Feb 5, 2015 | S | 4,465 | $107.8502 | D | 48,214 | D | |
| Common StockF3 | Feb 5, 2015 | S | 4,700 | $109.4684 | D | 43,514 | D | |
| Common StockF4 | Feb 5, 2015 | S | 14,940 | $108.3454 | D | 28,574 | D | |
| Common Stock | holding | — | — | — | 526 | I | By 401(k) | |
| Common Stock | holding | — | — | — | 4,456 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $63.95 | Feb 5, 2015 | M | 18,824 | D | Sep 16, 2009 | Sep 16, 2018 | Common Stock | 18,824 | 19,526 | D |
| Stock Option (Right to Buy) | $61.16 | Feb 5, 2015 | M | 6,686 | D | Sep 18, 2008 | Sep 18, 2017 | Common Stock | 6,686 | 0 | D |
Explanation of responses
- F1Transaction executed pursuant to a pre-planned trading program adopted by reporting person on December 4, 2014, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2This transaction was executed in multiple trades at prices ranging from $107.58 to $107.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $109.00 to $109.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $108.01 to $108.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.